- Brand name
- Tranexamic Acid Link Solution for injection
- Active ingredient
- Tranexamic acid
Consumer medicine information (CMI) leaflet
Please read this leaflet carefully before you start using Tranexamic Acid Link Solution for injection.Download CMI (PDF) Download large text CMI (PDF)
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully before you are given TRANEXAMIC ACID LINK injection. This leaflet answers some common questions about TRANEXAMIC ACID LINK.
It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you having an administration of TRANEXAMIC ACID LINK against the expected benefits it will have for you.
If you have any concerns about the administration of this medicine, ask your doctor or pharmacist.
Keep this leaflet you may need to read it again.
Tell your pharmacist or doctor as soon as possible if you do not feel well after you are administered TRANEXAMIC ACID LINK.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Tell your doctor, nurse or pharmacist if you notice any of the following and they worry you:
These are the more common side effects of TRANEXAMIC ACID LINK. Mostly these are mild and short-lived.
Following cardiac surgery, total knee replacement or total hip replacement surgery, tell your doctor or nurse immediately if you experience any of the following:
- irregular and often rapid heart beat
- heart attack
- slow or irregular heart beat
- cardiogenic shock caused by very low blood pressure. The symptoms are dizziness and light headedness, rapid, weak pulse, white skin, sweating, restlessness, loss of consciousness, fainting, rapid, shallow breathing, cold clammy skin and weakness.
- stroke. The symptoms of stroke are numbness or weakness of the arms or legs, headache, dizziness and confusion, visual disturbance, difficulty swallowing, slurred speech and loss of speech.
- kidney problems where you pass little or no urine, drowsiness, nausea, vomiting and breathlessness
- difficulty breathing
- a condition called deep vein thrombosis (DVT). The symptoms of DVT are pain and swelling in the large veins, usually in your legs. DVT may lead to complications such as blood clots in your lungs.
- bowel infarction caused by a restriction of blood supply to the bowels. You may experience severe abdominal pains and may pass bloody stools.
These are serious side effects. You may need urgent medical attention.
Tell your doctor immediately or go to Accident and Emergency at your nearest hospital if you notice any of the following:
- unexpected pain
- unexpected swelling in your legs or arms
- giddiness or dizziness
- allergic skin reactions
- changes in your eyesight
- convulsions, fits or seizures
- low blood pressure from rapid administration of TRANEXAMIC ACID LINK Solution for Injection.
These may be serious side effects. You may need urgent medical attention. These side effects are rare.
Other side effects not listed above may occur in some patients.
Tell your doctor if you notice any other side effects after administration of TRANEXAMIC ACID LINK.
Do not be alarmed by this list of possible side effects.
You may not experience any of them.
What it looks like
TRANEXAMIC ACID LINK Solution for Injection is a clear and colourless solution.
The active ingredient in TRANEXAMIC ACID LINK is tranexamic acid.
TRANEXAMIC ACID LINK ampoules each contains 100 mg/mL tranexamic acid.
The inactive ingredient is
- Sterile Water for Injections.
TRANEXAMIC ACID LINK Solution for Injection is available in packs of
- 5 x 5 mL ampoules each containing 500 mg tranexamic acid and 5 mL Water for Injections.
If you want to know more
If you have any questions about your treatment with TRANEXAMIC ACID LINK, ask your doctor or pharmacist.
In Australia by
Link Medical Products Pty Ltd
5 Apollo Street
Warriewood NSW 2102
Australian Register Number
Solution for Injection
500 mg/5 mL ampoule - AUST R 214485
This leaflet was last updated in August 2014.